Up a level |
(2024) Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of pharmaceutical and biomedical analysis. p. 115839. ISSN 1873-264X (Electronic) 0731-7085 (Linking)